What Are Mast Cells?

Mast cells are granule-rich immune cells of the myeloid lineage that reside in connective tissue and at mucosal surfaces, where they act as sentinels at the boundary between the body and its environment. They belong to the wider family of white blood cells, but unlike neutrophils or circulating lymphocytes they leave the bone marrow as immature progenitors and complete their differentiation inside peripheral tissue under the influence of stem cell factor and the KIT receptor. Paul Ehrlich first described them in 1878 after observing cells whose cytoplasmic granules stained metachromatically with aniline dyes, and named them for their swollen, well-fed appearance.

Mature mast cells are long-lived and concentrated in the skin, the airway and gut mucosa, and the perivascular and perineural spaces. Their position at these interfaces, combined with a store of preformed mediators that can be released within seconds, makes them the fastest-acting effector cells of the immediate hypersensitivity response and a central subject of allergy research.

Granule Contents and Mediator Release

Mast cell granules hold histamine, heparin proteoglycans, tumor necrosis factor, and the serine proteases tryptase and chymase, whose relative abundance distinguishes mucosal from connective tissue subsets in humans. Activation triggers three waves of output on different timescales. Exocytosis of preformed granule contents happens in seconds and drives vasodilation, increased vascular permeability, smooth muscle contraction, and itch. Arachidonic acid metabolites, chiefly prostaglandin D2 and leukotriene C4, are synthesized within minutes. Cytokines and chemokines including interleukin-4, interleukin-5, interleukin-13, and CCL2 follow over hours and recruit eosinophils and T cells. Because this cascade is stepwise and pharmacologically tractable, granule exocytosis has become a target for drug development in mast cell driven disease.

Activation Through the High-Affinity IgE Receptor

The classical activation route runs through FcεRI, the high-affinity receptor for immunoglobulin E, which mast cells express constitutively and which binds IgE with a dissociation constant near 10⁻¹⁰ M. Receptor-bound IgE persists on the cell surface for weeks, so the cell is effectively armed in advance. When a multivalent allergen cross-links adjacent IgE molecules, the aggregated receptors recruit the Src-family kinases Lyn and Fyn and the tyrosine kinase Syk, producing a phosphorylation cascade that raises intracellular calcium and drives granule fusion with the plasma membrane. The role of IgE and mast cells in allergic disease explains why anti-IgE antibodies such as omalizumab reduce symptoms by lowering free IgE and downregulating FcεRI expression. Mast cells also respond to complement fragments C3a and C5a, neuropeptides, certain drugs acting on the MRGPRX2 receptor, and physical stimuli.

Functions Beyond Allergy

Allergy is the most visible mast cell activity but not the original one. These cells contribute to innate defense against helminth parasites and bacterial infection, degrade snake and insect venom components through their proteases, and participate in wound repair, angiogenesis, and tissue remodeling. Regulatory circuits normally restrain them, and failure of that control produces disease: systemic mastocytosis follows clonal expansion driven by the activating KIT D816V mutation, while mast cell activation syndrome involves episodic mediator release without clonal expansion. Work on the regulation of mast cell responses in health and disease traces how inhibitory receptors, phosphatases, and microenvironmental signals set the activation threshold.

Applications

Mast cell biology has applications in a range of fields, including:

• Allergy diagnostics, where serum tryptase serves as a marker of systemic activation
• Drug development, including anti-IgE biologics, antihistamines, and KIT inhibitors for mastocytosis
• Biosensor and organ-on-chip design, using cultured mast cells as reporters of allergen exposure
• Vaccine research, where mast cell activators have been tested as mucosal adjuvants
• Dermatology and gastroenterology, in the study of chronic urticaria and irritable bowel syndrome